StonvexLoading…
StonvexStonvexStonvexCore line items from LB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $62.71M | $51.01M | $199.09M | $142.31M | $91.48M |
Operating Income | Not available | $29.18M | $118.50M | $84.42M | $53.54M |
Net Income | Not available | $8.71M | $30.13M | $22.07M | $13.97M |
EPS (Diluted) | $0.45 | $0.23 | $0.94 | $0.70 | $0.44 |
Total Assets | Not available | $1.36B | $1.37B | $1.08B | $1.07B |
Total Liabilities | Not available | $554.12M | $572.07M | $380.09M | $381.42M |
Cash & Equivalents | Not available | $29.68M | $30.74M | $28.32M | $20.34M |
Free Cash Flow OCF − CapEx | Not available | $40.94M | $122.04M | $85.66M | $51.94M |
Shares Outstanding | Not available | 77.08M | 76.54M | 76.46M | 76.43M |